Terazosin, finasteride, or both in benign prostatic hyperplasia.
Thien
T
T
Lenders
J W
JW
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced*; D008297:Male; D011224:Prazosin / Q000009:adverse effects / Q000031:analogs & derivatives*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; C041226:Terazosin; D011224:Prazosin